NO760162L - - Google Patents
Info
- Publication number
- NO760162L NO760162L NO760162A NO760162A NO760162L NO 760162 L NO760162 L NO 760162L NO 760162 A NO760162 A NO 760162A NO 760162 A NO760162 A NO 760162A NO 760162 L NO760162 L NO 760162L
- Authority
- NO
- Norway
- Prior art keywords
- tartar
- solution
- hydroxyapatite
- polyphosphate
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 18
- 150000001768 cations Chemical class 0.000 claims description 15
- 229920000388 Polyphosphate Polymers 0.000 claims description 14
- 239000001205 polyphosphate Substances 0.000 claims description 14
- 235000011176 polyphosphates Nutrition 0.000 claims description 14
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 claims description 6
- 235000019982 sodium hexametaphosphate Nutrition 0.000 claims description 6
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 238000011321 prophylaxis Methods 0.000 claims description 2
- 230000000737 periodic effect Effects 0.000 claims 1
- 208000006558 Dental Calculus Diseases 0.000 description 19
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 17
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 17
- 239000000243 solution Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 description 9
- 239000011707 mineral Substances 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000002845 discoloration Methods 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 5
- 239000000606 toothpaste Substances 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 229940005740 hexametaphosphate Drugs 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 230000001089 mineralizing effect Effects 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- OYPRJOBELJOOCE-BKFZFHPZSA-N Calcium-45 Chemical compound [45Ca] OYPRJOBELJOOCE-BKFZFHPZSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 230000033558 biomineral tissue development Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000013068 control sample Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 230000010736 Chelating Activity Effects 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910001451 bismuth ion Inorganic materials 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-L diphosphonate(2-) Chemical compound [O-]P(=O)OP([O-])=O XQRLCLUYWUNEEH-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54201175A | 1975-01-17 | 1975-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO760162L true NO760162L (ja) | 1976-07-20 |
Family
ID=24161988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO760162A NO760162L (ja) | 1975-01-17 | 1976-01-19 |
Country Status (7)
| Country | Link |
|---|---|
| BE (1) | BE837701A (ja) |
| DK (1) | DK18776A (ja) |
| FR (1) | FR2297631A1 (ja) |
| NL (1) | NL7600503A (ja) |
| NO (1) | NO760162L (ja) |
| SE (1) | SE7600504L (ja) |
| ZA (1) | ZA76272B (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA783241B (en) * | 1977-06-23 | 1979-06-27 | Ici Ltd | Method |
| JPH0791177B2 (ja) * | 1986-07-24 | 1995-10-04 | ライオン株式会社 | 歯石予防用口腔用組成物 |
| US5296217A (en) * | 1992-06-15 | 1994-03-22 | Indiana University Foundation | Methods for preventing dental calculus in domestic animals |
| US6713049B1 (en) | 1999-11-12 | 2004-03-30 | The Procter & Gamble Company | Oral compositions providing optimal surface conditioning |
| CA2387956C (en) | 1999-11-12 | 2007-02-06 | The Procter & Gamble Company | Improved dual phase stannous oral compositions |
| US10470985B2 (en) | 1999-11-12 | 2019-11-12 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US20040146466A1 (en) | 1999-11-12 | 2004-07-29 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| JP3860471B2 (ja) | 1999-11-12 | 2006-12-20 | ザ プロクター アンド ギャンブル カンパニー | 改良された第１錫系口腔組成物 |
| US10123953B2 (en) | 2012-06-21 | 2018-11-13 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
| US11191709B2 (en) | 2019-04-26 | 2021-12-07 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA721351B (en) * | 1971-03-22 | 1973-10-31 | Colgate Palmolive Co | Stable dentifrice |
-
1976
- 1976-01-19 NO NO760162A patent/NO760162L/no unknown
- 1976-01-19 FR FR7601302A patent/FR2297631A1/fr active Granted
- 1976-01-19 BE BE163624A patent/BE837701A/xx unknown
- 1976-01-19 DK DK18776*#A patent/DK18776A/da not_active Application Discontinuation
- 1976-01-19 ZA ZA760272A patent/ZA76272B/xx unknown
- 1976-01-19 NL NL7600503A patent/NL7600503A/xx not_active Application Discontinuation
- 1976-01-19 SE SE7600504A patent/SE7600504L/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2297631A1 (fr) | 1976-08-13 |
| FR2297631B1 (ja) | 1979-06-29 |
| SE7600504L (sv) | 1976-07-18 |
| ZA76272B (en) | 1977-03-30 |
| BE837701A (fr) | 1976-07-19 |
| DK18776A (da) | 1976-07-18 |
| NL7600503A (nl) | 1976-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4556561A (en) | Compositions and methods for topically fluoridating and/or mineralizing dental tissue | |
| US5437857A (en) | Methods and compositions for mineralizing and fluoridating calcified tissues | |
| Lussi et al. | Fluorides—mode of action and recommendations for use | |
| EP0006708B1 (en) | Composition for controlling dental plaque and calculus | |
| DK163207B (da) | Mundplejepraeparat, tandpastadispenser indeholdende praeparatet og fremgangsmaade til at reducere eller forebygge inaktiveringen af en vandoploeselig fluoridkilde | |
| JPS63101312A (ja) | 口腔用製品 | |
| JPH10511956A (ja) | 嗽剤、歯磨き及びゲルにおける弗化カルシウム形成の制御 | |
| WO2013117913A2 (en) | Multicomponent oral care composition | |
| NO760162L (ja) | ||
| Gilbert et al. | The oral disposition of zinc following the use of an anticalculus toothpaste containing 0.5% zinc citrate | |
| Baig et al. | Protective effects of S n F 2–Part I. Mineral solubilisation studies on powdered apatite | |
| CA2626140A1 (en) | Fluoride-calcium compositions, dental products, and methods for providing dental fluoride | |
| CA2953418C (en) | Anti-calculus oral compositions | |
| EP0129201A2 (en) | Oral hygiene compositions | |
| EP0695165A1 (en) | Method of making a tartar control baking soda dentifrice | |
| US3666855A (en) | Oral compositions and methods for retarding dental caries and calculus | |
| Murata et al. | Fluoridation of hydroxyapatite powder by ammonium hexafluorosilicate | |
| EP3634362A1 (en) | Oral care composition | |
| JPH0134966B2 (ja) | ||
| DE2602981A1 (de) | Mittel zur dentalen prophylaxe | |
| EP0428492B1 (en) | Improvement in the fluoride stability in dicalcium phosphate dihydrate composition | |
| JPS6257164B2 (ja) | ||
| JP2738021B2 (ja) | 歯磨用組成物 | |
| JPH01163127A (ja) | 知覚過敏症治癒用組成物 | |
| NO165897B (no) | Programmerbart koblingsur. |